Combined left atrial appendage occlusion and catheter ablation procedure for left atrial arrhythmias: A real‐world, propensity‐matched analysis
Stefan Preisendörfer,Muhammad T. Ayub,Aakash Sheth,George Y. Jabbour,Madhurmeet Singh,Chinmay P. Patel,Hemal Gada,Aditya Bhonsale,Mehak Dhande,Nathan A. Estes,Krishna Kancharla,Dustin E. Kliner,Amber Makani,Aditi Naniwadekar,Alaa Shalaby,Virginia Singla,Andrew Voigt,Samir F. Saba,Sandeep K. Jain
DOI: https://doi.org/10.1111/jce.16466
IF: 2.7
2024-10-17
Journal of Cardiovascular Electrophysiology
Abstract:Introduction Real‐world studies comparing safety and efficacy of combined percutaneous left atrial appendage occlusion (LAAO) and catheter ablation (CA) to LAAO alone are limited. Methods Patients from a large US hospital system undergoing combined LAAO and left‐atrial CA from 8/2020 to 2/2024 were retrospectively analyzed and compared to a control group undergoing LAAO alone. Controls were identified using a 1:2 propensity score match based on LAAO device type (Watchman FLX vs. Amulet), CHA2D2‐VASc and Hypertension, Abnormal renal/liver function, Stroke, Bleeding history or predisposition, Labile international normalized ratio [INR], Elderly, Drugs/alcohol (HAS‐BLED) scores and compared for safety, sealing performance and clinical outcomes at 6 months. Results Patients were younger in the combined (n = 72) than in the control group (n = 144, 70.2 ± 7.3 vs. 76.7 ± 6.9 years, p
cardiac & cardiovascular systems